Market Overview:
The global albendazole and lvermectin market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of parasitic infections, rising demand for animal health products, and growing awareness about livestock health and hygiene. Albendazole is an anthelmintic drug used in the treatment of parasitic infections caused by nematodes (roundworms) and cestodes (tapeworms). Lvermectin is a macrocyclic lactone antibiotic that inhibits glutamate-gated chloride channels in invertebrates, which leads to paralysis and death of the parasites. The two drugs are used together for treating mixed infections caused by both nematodes and cestodes. Based on type, the global albendazole and lvermectin market has been segmented into premixes, powders, pills/tablets/capsules, injectables/syrups/suspensions),and others). Geographically,.LatinAmerica,.Europe,.AsiaPacific.,and Middle East & Africa ).
Product Definition:
Albendazole is a benzimidazole antihelmintic agent that is used to treat a variety of worm infections. It works by inhibiting the synthesis of DNA in the worms, which eventually leads to their death.Lvermectin is an avermectin derivative that is used as an antiparasitic agent. It binds to glutamate-gated chloride channels in invertebrate nerve and muscle cells, leading to paralysis and death of the parasites. Both albendazole and lvermectin are important drugs for treating worm infections in humans and animals.
Premix:
premix is a mixture of active ingredients, which are added to the base drug during manufacturing process. It helps in increasing the efficiency and potency of final product.
Powder:
Powder is a fine, white crystalline powder and is insoluble in water. It has a mild pleasant odor similar to fresh snow. Albendazole and Lvermectin are the most commonly used brands of powder for dogs as they are very effective against parasitic infections such as heartworm, roundworm, hookworms, etc. Powder form of these medicines can be administered directly to the dog or mixed with food & milk for oral use.
Application Insights:
The treatment of external parasites segment led the global albendazole and lvermectin market in 2017. This is attributed to increasing product usage for the removal of ticks, mites, fleas and flies from animals. Albendazole is used for treating infestations by hookworms, ascarids, whipworms and nematodes among other parasites. Lvermectin is used for treating infections caused by roundworms (ascarids), threadworms (ticks) and pinworm (boys). These products are also effective against skin diseases such as mange because they kill both adult & juvenile worms without having any negative impact on humans. Therefore, these products are expected to be highly consumed in parasite management programs across the globe over the forecast period.
Regional Analysis:
Europe dominated the global albendazole and lvermectin market in 2017. The presence of stringent regulations pertaining to animal health is one of the major factors responsible for this dominance. For instance, according to European Union (EU) directives, all animals entering EU countries must be screened for tapeworms before shipment. This screening process helps ensure that no tapeworm-infected meat enters the food chain thus protecting human health from contamination.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the major growth drivers for the Albendazole and Lvermectin market. According to a study by the World Health Organization (WHO), over 1.5 billion people are affected by parasitic worms, globally. This number is expected to increase in the coming years, owing to the rising population and changing lifestyle habits.
- Growing awareness about preventive measures: There is a growing awareness among people about preventive measures against parasitic infections such as Albendazole and Lvermectin administration. This is driving demand for these drugs, thereby propelling market growth.
- Rising incidence of travel-related diseases: The incidence of travel-related diseases has been on the rise in recent years due to increased international travel activities by people across different geographies. This has led to an increase in demand for Albendazole and Lvermectin drugs as they are effective against most types of parasites that cause these diseases .
Scope Of The Report
Report Attributes
Report Details
Report Title
Albendazole and Lvermectin Market Research Report
By Type
Premix, Powder, Pill
By Application
Treatment of External Parasites, Treatment of Internal Parasites
By Companies
Shandong Luxi Veterinary Pharmaceutical Co. Ltd, Shijiazhuang Shimu Pharmaceutical co. Ltd, Jinhe Biotechnology Co., Ltd, Zhengzhou Yuxiang Agricultural Science and Technology co. Ltd, Sichuan Hengtong Animal Protection Biotechnology Co. Ltd, IMPERIA LIFESCIENCES PVT LTD, Geevet Remedies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Albendazole and Lvermectin Market Report Segments:
The global Albendazole and Lvermectin market is segmented on the basis of:
Types
Premix, Powder, Pill
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Treatment of External Parasites, Treatment of Internal Parasites
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shandong Luxi Veterinary Pharmaceutical Co. Ltd
- Shijiazhuang Shimu Pharmaceutical co. Ltd
- Jinhe Biotechnology Co., Ltd
- Zhengzhou Yuxiang Agricultural Science and Technology co. Ltd
- Sichuan Hengtong Animal Protection Biotechnology Co. Ltd
- IMPERIA LIFESCIENCES PVT LTD
- Geevet Remedies
Highlights of The Albendazole and Lvermectin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Premix
- Powder
- Pill
- By Application:
- Treatment of External Parasites
- Treatment of Internal Parasites
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Albendazole and Lvermectin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Albendazole is an antiparasitic medication used to treat infections caused by parasites such as roundworms, hookworms, and tapeworms. Lvermectin is a medication used to treat infections caused by nematodes (roundworm, hookworm, and pinworm).
Some of the major companies in the albendazole and lvermectin market are Shandong Luxi Veterinary Pharmaceutical Co. Ltd, Shijiazhuang Shimu Pharmaceutical co. Ltd, Jinhe Biotechnology Co., Ltd, Zhengzhou Yuxiang Agricultural Science and Technology co. Ltd, Sichuan Hengtong Animal Protection Biotechnology Co. Ltd, IMPERIA LIFESCIENCES PVT LTD, Geevet Remedies.
The albendazole and lvermectin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Albendazole and Lvermectin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Albendazole and Lvermectin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Albendazole and Lvermectin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Albendazole and Lvermectin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Albendazole and Lvermectin Market Size & Forecast, 2020-2028
4.5.1 Albendazole and Lvermectin Market Size and Y-o-Y Growth
4.5.2 Albendazole and Lvermectin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Premix
5.2.2 Powder
5.2.3 Pill
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Treatment of External Parasites
6.2.2 Treatment of Internal Parasites
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Albendazole and Lvermectin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Albendazole and Lvermectin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Premix
9.6.2 Powder
9.6.3 Pill
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Treatment of External Parasites
9.10.2 Treatment of Internal Parasites
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Premix
10.6.2 Powder
10.6.3 Pill
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Treatment of External Parasites
10.10.2 Treatment of Internal Parasites
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Premix
11.6.2 Powder
11.6.3 Pill
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Treatment of External Parasites
11.10.2 Treatment of Internal Parasites
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Premix
12.6.2 Powder
12.6.3 Pill
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Treatment of External Parasites
12.10.2 Treatment of Internal Parasites
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Premix
13.6.2 Powder
13.6.3 Pill
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Treatment of External Parasites
13.10.2 Treatment of Internal Parasites
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Albendazole and Lvermectin Market: Competitive Dashboard
14.2 Global Albendazole and Lvermectin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Shandong Luxi Veterinary Pharmaceutical Co. Ltd
14.3.2 Shijiazhuang Shimu Pharmaceutical co. Ltd
14.3.3 Jinhe Biotechnology Co., Ltd
14.3.4 Zhengzhou Yuxiang Agricultural Science and Technology co. Ltd
14.3.5 Sichuan Hengtong Animal Protection Biotechnology Co. Ltd
14.3.6 IMPERIA LIFESCIENCES PVT LTD
14.3.7 Geevet Remedies
